BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Park H, Jeong D, Nguyen P, Henry L, Hoang J, Kim Y, Sheen E, Nguyen MH. Economic and clinical burden of viral hepatitis in California: A population-based study with longitudinal analysis. PLoS One 2018;13:e0196452. [PMID: 29708985 DOI: 10.1371/journal.pone.0196452] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Congly SE, Syed A, Haylock-jacobs S, Israelson H, Pinto J, Williams S, Lee SS, Coffin CS. A real-world retrospective single-centre study of the cost-effectiveness and long-term outcomes of pegylated interferon for chronic hepatitis B. Canadian Liver Journal 2023. [DOI: 10.3138/canlivj-2022-0043] [Reference Citation Analysis]
2 Jiang X, Diaby V, Vouri SM, Lo-Ciganic W, Parker RL, Wang W, Chang SH, Wilson DL, Henry L, Park H. Economic Impact of Universal Hepatitis C Virus Testing for Middle-Aged Adults Who Inject Drugs. Am J Prev Med 2023;64:96-104. [PMID: 36257884 DOI: 10.1016/j.amepre.2022.08.016] [Reference Citation Analysis]
3 Feld JJ, Lawitz E, Nguyen T, Lalezari J, Hassanein T, Martin P, Han S, Dieterich D, Giard J, De La Rosa G, Ahmad A, Luo E, Conery AL, Adda N. EDP-514 in healthy subjects and nucleos(t)ide reverse transcriptase inhibitor-suppressed patients with chronic hepatitis B. Antiviral Therapy 2022;27:135965352211278. [DOI: 10.1177/13596535221127848] [Reference Citation Analysis]
4 Du J, Wang Z, Wu B. Expanding Antiviral Prophylaxis During Pregnancy to Prevent Perinatal Hepatitis B Virus Infection: A Cost-effectiveness Study. Open Forum Infect Dis 2020;7:ofaa137. [PMID: 32478119 DOI: 10.1093/ofid/ofaa137] [Reference Citation Analysis]
5 Adjei CA, Stutterheim SE, Naab F, Ruiter RAC. Barriers to chronic Hepatitis B treatment and care in Ghana: A qualitative study with people with Hepatitis B and healthcare providers. PLoS One. 2019;14:e0225830. [PMID: 31794577 DOI: 10.1371/journal.pone.0225830] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
6 Nguyen MH, Lim JK, Burak Ozbay A, Fraysse J, Liou I, Meyer N, Dusheiko G, Gordon SC. Advancing Age and Comorbidity in a US Insured Population-Based Cohort of Patients With Chronic Hepatitis B. Hepatology 2019;69:959-73. [PMID: 30175482 DOI: 10.1002/hep.30246] [Cited by in Crossref: 46] [Cited by in F6Publishing: 29] [Article Influence: 11.5] [Reference Citation Analysis]
7 Park H, Jeong D, Nguyen P, Henry L, Hoang J, Kim Y, Sheen E, Nguyen MH. Correction: Economic and clinical burden of viral hepatitis in California: A population-based study with longitudinal analysis. PLoS One 2018;13:e0209715. [PMID: 30566488 DOI: 10.1371/journal.pone.0209715] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]